Hypernet- Hypertension Screening NCT00208845

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Terminated

Study information
Verified date	November 2013
Source	Emory University
Contact	n/a
Is FDA regulated	No
Health authority	United States: Institutional Review Board
Study type	Observational

Identify untreated, asymptomatic hypertension in ER patients

this was a prospective study done with no intervention- the study has since been completed

Recruitment information / eligibility
Status	Terminated
Enrollment	100
Est. completion date
Est. primary completion date
Accepts healthy volunteers	No
Gender	Both
Age group	18 Years and older
Eligibility	Inclusion Criteria: - asymptomatic hypertension Exclusion Criteria: - cardiac symptoms

Observational Model: Cohort, Time Perspective: Prospective

Locations
Country	Name	City	State
n/a

Sponsors *(2)*
Lead Sponsor	Collaborator
Emory University	University of California, Los Angeles